No Data
No Data
Insider decrases its stake in Chordia Therapeutics(190A.JP) to 4.51%
On Oct 3, SMBCベンチャーキャピタル株式会社 submitted the Change Report to Ministry of Finance. The report shows that SMBCベンチャーキャピタル株式会社 decreased their holdings in $Chordia Therapeutics(190A.JP)$, with their
Chordia Therapeutics Unveils Promising Cancer Drug Trial
Shinka, Yumetenbo, etc. [5% Rule of Emerging Markets]
<149A> Shinca SBI Investment Co., Ltd. shareholding ratio 10.43% → 10.55%, obligation to report starting on September 19, 2024. <190A> Chordia Therapeutics Co., Ltd. Tokyo University Co-Creation Platform Development Co., Ltd. shareholding ratio 5.14% → 3.77%, obligation to report starting on September 19, 2024. <218A> LiberaWare Bonds Invest.
Insider decrases its stake in Chordia Therapeutics(190A.JP) to 3.77%
On Sep 27, 東京大学協創プラットフォーム開発株式会社 submitted the Change Report to Ministry of Finance. The report shows that 東京大学協創プラットフォーム開発株式会社 decreased their holdings in $Chordia Therapeutics(190A.JP)$, with
Chordia Therapeutics, OPRO, etc.
<190A> Chordia Therapeutics Co., Ltd. Mitsui Sumitomo DS Asset Management Co., Ltd. Shareholding Ratio 6.60% → 5.60% Reporting Obligation Date 2024/09/13 <218A> LiberaWare Bonds Investment Group Co., Ltd. Shareholding Ratio 5.16% → 2.94% Reporting Obligation Date 2024/09/19 <228A> Opro Co., Ltd. Mitsui
Mitsui Sumitomo DS Asset Management decrases its stake in Chordia Therapeutics(190A.JP) to 5.6%
On Sep 24, Mitsui Sumitomo DS Asset Management and related parties submitted the Change Report to Ministry of Finance. The report shows that Mitsui Sumitomo DS Asset Management and related parties
No Data
No Data